Key Points from the Announcement
- The board of directors of Gaush Meditech Ltd has announced a change in the name of its principal share registrar and transfer office in the Cayman Islands.
- Effective April 17, 2026, the registrar’s name will change from Harneys Fiduciary (Cayman) Limited to Ascentium (Cayman) Limited.
- The physical address of the registrar and transfer office remains unchanged.
- The announcement was issued by Mr. Gao Tieta, the Chairman and Executive Director of Gaush Meditech Ltd.
- The board composition includes several executive, non-executive, and independent non-executive directors.
Details for Shareholders and Potential Impact on Share Value
This announcement is of administrative nature and concerns the change in the name of the company’s principal share registrar and transfer office in the Cayman Islands. The function and address of the registrar remain unchanged, ensuring continuity for shareholders regarding share registration and transfer services.
Shareholders should note:
- There will be no disruption in services relating to share registration or transfers.
- All previous legal and operational records remain valid, as only the registrar’s name changes.
- This change does not affect the company’s operations, financial position, or shareholder rights.
Potential Price Sensitivity:
Based on the details provided, this is a routine administrative update and does not contain information that would be regarded as price sensitive or likely to affect the share price of Gaush Meditech Ltd. There is no indication of any impact on the company’s financials, operations, or shareholder value.
Board Composition
- Chairman and Executive Director: Mr. Gao Tieta
- Executive Directors: Mr. Liu Xinwei, Mr. Zhao Xinli, Mr. Zhang Jianjun, Ms. Li Wenqi
- Non-Executive Director: Dr. David Guowei Wang
- Independent Non-Executive Directors: Mr. Feng Xin, Mr. Wang Li-Shin, Mr. Chan Fan Shing
Conclusion
Investors should view this announcement as a procedural update with no material impact on the company’s business or share value. No action is required from shareholders.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with professional advisors before making any investment decisions. The author and publisher are not responsible for any losses incurred as a result of reliance on this information.
View GAUSH MEDITECH Historical chart here
